Filter
1611
Text search:
Epidemiological
update
Featured
203
366
Language
Document type
683
322
299
106
98
38
35
20
7
1
1
Countries / Regions
76
61
47
40
32
29
29
26
26
25
23
22
21
21
20
20
19
19
16
16
16
15
15
15
14
13
13
13
12
12
11
11
10
10
10
9
9
9
8
8
8
8
7
7
7
7
7
7
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
516
147
96
69
57
20
18
Toolboxes
260
117
111
110
68
66
58
49
47
46
40
39
36
26
23
20
18
18
16
15
10
9
4
2
2
Accessed November, 2017
Policy framework.
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
Manual for Early Implementation
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
Therapeutics Information and Pharmacovigilance Centre | TIPC
Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in the global effort to achieve and maintain a polio free world. However, fragmented approaches and short-term planning pose considera
...
There has never been a more critical moment to invest in WHO, and strengthen the unique role it plays in global health. Now is the time to sustainably finance WHO and invest in a healthy return for all.
Background paper 8
The Independent Panel for Pandemic Preparedness and Response
May 2021
Systematic screening for active tuberculosis: an operational guide.